Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 10 PODD Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript
May 10 XOMA XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss
May 10 ZURA Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments
May 10 LLY Lilly could partner with Cipla to market GLP-1 drugs in India - report
May 10 HALO Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout
May 10 PODD Insulet Corp (PODD) Reports Strong Q1 2024 Results and Raises Full-Year Guidance
May 10 LLY Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
May 10 NVO One in eight U.S. adults admits to GLP-1 usage as public awareness climbs
May 10 LLY One in eight U.S. adults admits to GLP-1 usage as public awareness climbs
May 10 LLY Dividend Roundup: Eli Lilly, American Express, Microsoft, Delta Air Lines, and more
May 10 LLY How A Top Fund Beats The Market By Owning Future Leaders
May 10 LLY Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
May 10 LLY Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
May 10 LLY UPDATE 2-India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
May 10 NVO Novo Nordisk enters deal to develop obesity therapy
May 10 PODD Insulet Corporation 2024 Q1 - Results - Earnings Call Presentation
May 10 PODD Insulet Corporation (PODD) Q1 2024 Earnings Call Transcript
May 9 VTVT vTv Therapeutics GAAP EPS of -$1.17, revenue of $1M
May 9 PODD Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings
May 9 VTVT vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags